Opinion: Cure ‘futures’ offer a way to pay for million-dollar medicines
Effective new drugs can make the world a better place — unless they aren’t accessible because those making the breakthroughs charge an enormous price to get a decent profit because they can, or because their investors demand it.
People who create viable businesses and their investors have a right to earn a return on the resources they expend to solve a problem, including finding cures for previously incurable diseases. But that is turning out to be problematic when it comes to new medicines, especially those with million-dollar price tags.
A recent focused on a newly approved leukemia treatment with a high success rate. The total treatment cost
